Dr. Srinivas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-725-9113
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1991 - 1994
- Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 1989 - 1991
- Madras Medical CollegeClass of 1987
Certifications & Licensure
- CA State Medical License 1991 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- 4208 citationsNivolumab versus Everolimus in Advanced Renal-Cell CarcinomaRobert J. Motzer, Bernard Escudier, David F. McDermott, Saby George, Hans J. Hammers
The New England Journal of Medicine. 2015-11-04 - 57 citationsManagement of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conferenc...Silke Gillessen, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi
European Journal of Cancer. 2023-05-01 - 62 citationsMyocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint Inhibitors.Sarah Waliany, Joel W. Neal, Sunil Reddy, Heather A. Wakelee, Sumit A. Shah
JACC. Cardiooncology. 2021-03-01
Press Mentions
- Effective Treatment Options and Sequencing for Patients with Castration-Resistant Prostate CancerJuly 26th, 2023
- Androgen Deprivation Therapy and Prostate Cancer: Bone Health, Survivorship, and Side EffectsJuly 26th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: